摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3,4-Dimethyl-1-azacyclooct-5-yn-1-yl)pent-4-enoic acid

中文名称
——
中文别名
——
英文名称
4-(3,4-Dimethyl-1-azacyclooct-5-yn-1-yl)pent-4-enoic acid
英文别名
4-(3,4-dimethyl-1-azacyclooct-5-yn-1-yl)pent-4-enoic acid
4-(3,4-Dimethyl-1-azacyclooct-5-yn-1-yl)pent-4-enoic acid化学式
CAS
——
化学式
C14H21NO2
mdl
——
分子量
235.32
InChiKey
TXAKKWLGBBCUDS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Compositions and Methods for Modification of Biomolecules
    申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    公开号:US20160243135A1
    公开(公告)日:2016-08-25
    The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
    本发明提供了经过改性的环烷炔化合物;以及利用这些化合物修饰生物分子的方法。本发明特征在于可以在生理条件下进行的环加成反应。一般而言,本发明涉及将改性的环烷炔与目标生物分子上的偶氮基团反应,生成共价修饰的生物分子。该反应的选择性和其与相环境的兼容性使其能够应用于体内(例如,细胞表面或细胞内)和体外(例如,合成肽和其他聚合物,生产改性的(例如,标记的)氨基酸)。
  • D-Amino Acid Derivative-Modified Peptidoglycan and Methods of Use Thereof
    申请人:The Regents of the University of California
    公开号:US20140170183A1
    公开(公告)日:2014-06-19
    The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
  • D-AMINO ACID DERIVATIVE-MODIFIED PEPTIDOGLYCAN AND METHODS OF USE THEREOF
    申请人:The Regents of the University of California
    公开号:US20170021013A1
    公开(公告)日:2017-01-26
    The present disclosure provides modified bacteria and modified peptidoglycan comprising modified D-amino acids; compositions comprising the modified bacteria or peptidoglycan; and methods of using the modified bacteria or peptidoglycan. The modified D-amino acids include a bioorthogonal functional group such as an azide, an alkyne or a norbornene group. Also provided are modified peptidoglycans conjugated to a molecule of interest via a linker.
  • US9260371B2
    申请人:——
    公开号:US9260371B2
    公开(公告)日:2016-02-16
  • US9303068B2
    申请人:——
    公开号:US9303068B2
    公开(公告)日:2016-04-05
查看更多